Evaluation of Serum-Free Culture Conditions Able to Support the Ex Vivo Expansion and Engraftment of Human Hematopoietic Stem Cells in the Human-to-Sheep Xenograft Model
- 1 October 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Hematotherapy & Stem Cell Research
- Vol. 9 (5) , 683-693
- https://doi.org/10.1089/15258160050196722
Abstract
To develop culture conditions devoid of serum that would support the ex vivo expansion and maintenance of hematopoietic stem cells (HSC) with engraftment capability, we performed in vitro studies in which phenotypic and functional expansion of putative HSC populations were evaluated. We then used the human-sheep xenograft model to evaluate the engraftment potential of the ex vivo expanded cells. Adult human bone marrow CD34+-enriched cells were cultured in QBSF-60 for 14 days with or without fetal bovine serum (FBS) in the presence of interleukin-3 (IL-3), IL-6, and stem cell factor (SCF), and analyzed at days 0, 3, 7, and 14 for expansion, phenotype, clonogenic ability, and cell cycling status. Although there was a progressive expansion of numbers of cells in both groups, the group cultured with serum exhibited more than twice the expansion seen in the group without serum at all time points. The phenotypic analysis of the cultured cells showed an increase in the absolute numbers of CD34+ cells in both groups. However, when we evaluated the presence of CD34+ CD38- cells, this population persisted in significantly higher numbers in the group cultured without serum, with maximal output of CD34+ CD38- cells seen at 3 and 7 days. A higher total clonogenic potential was found in the serum-free cultures. To evaluate the in vivo engraftment potential of these cultured cells, 19 sheep fetuses were each injected i.p. with 9 × 105 cells either fresh or cultured in the conditions described above. Although all the transplanted fetal sheep showed the presence of human cells in their bone marrow (BM), the highest levels of long-term engraftment in primary recipients were obtained with the fraction of cells cultured for 3 days followed by 7 days in the absence of serum. In the secondary sheep recipients, the highest level of long-term engraftment was also achieved in sheep that received cells from primary recipients that had received cultured cells in serum-free conditions for 3 days.Keywords
This publication has 30 references indexed in Scilit:
- Intrinsic potential of phenotypically defined human hemopoietic stem cells to self-renew in short-term in vitro culturesExperimental Hematology, 1999
- Differential Kinetics of Primitive Hematopoietic Cells Assayed In Vitro and In Vivo During Serum‐Free Suspension Culture of CD34 + Blood Progenitor CellsThe International Journal of Cell Cloning, 1999
- Engraftment and Multilineage Expression of Human Bone Marrow CD34− Cells In VivoaAnnals of the New York Academy of Sciences, 1999
- Transplantation of hematopoietic stem cells in uteroThe International Journal of Cell Cloning, 1997
- Tumor Cell Contamination of Bone Marrow Harvest Products: Clinical Consequences in a Cohort of Advanced-Stage Breast Cancer Patients Undergoing High-Dose ChemotherapyJournal of Hematotherapy, 1996
- Large-Scale Selection of CD34+ Peripheral Blood Progenitors and Expansion of Neutrophil Precursors for Clinical ApplicationsJournal of Hematotherapy, 1996
- Hematopoietic Transplant Potential of Unrelated Cord Blood: Critical IssuesJournal of Hematotherapy, 1996
- Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium.Proceedings of the National Academy of Sciences, 1996
- Use of hematopoietic growth factors for in vitro expansion of precursor cell populationsCurrent Opinion in Hematology, 1995
- A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantificationCytometry, 1991